Challenges of using real world data in research and clinical trials
Introduction Patient and health information obtained outside of clinical trial settings is referred to as real world data (RWD). Analyzing RWD leads to […]
Preserving Patient Data Privacy and Security in the Face of Cyber Attacks
Recent cyber attacks targeting major U.S. health organizations underscore the critical importance of safeguarding sensitive patient data privacy and security as well […]
The benefits of leveraging real world data and evidence in clinical research and trials
Introduction Benefits of Real-World Data in Clinical Research What is Real World Data (RWD) and Real World Evidence (RWE)? Real world data […]
Unlocking insights: how real world data is shaping clinical research and trials
Introduction Clinical trials are a vital stage in the drug development process and are used to evaluate the safety and effectiveness of […]
Facilitating the establishment of high-quality patient registries
Patient registries are essential tools for collecting and analyzing data on specific diseases, conditions, or treatments. They provide valuable insights into patient outcomes, […]
Lifebit CEO, Dr. Maria Dunford, Accompanies Greek Prime Minister on Trade Visit to India
LONDON, 27 February 2024 – Lifebit India trade visit Dr. Maria Dunford, CEO of Lifebit, has been selected as one of 10 […]
Lifebit Empowers Pharma Industry with Unprecedented Access to Multi-Omic and Health Data from Over 100 Million Patients Worldwide
LONDON, 26 February 2024 Global biotechnology leader, Lifebit, achieves a groundbreaking milestone, unlocking the potential of diverse data to accelerate pharmaceutical research […]
Lifebit announces expansion into Asia Pacific and Japan
Lifebit Asia Pacific expansion: New R&D Centre in Singapore to advance collaboration with Synapxe and Singapore’s public healthcare sector for precision medicine […]
Four key benefits of using patient registries to progress rare disease insights
Rare diseases impact between approximately 250-450 million people globally, but they often receive less attention and funding than more common diseases. This can […]
Creating research-ready data from 135,000 cancer, rare disease & COVID-19 participants
Introduction Ultimately, the goal of creating research-ready health data is to benefit public health. Around the world, organisations across the healthcare system […]
Celebrating International Day of Women and Girls in Science
On February 11th, we celebrate the International Day of Women and Girls in Science, a global initiative recognising women’s pivotal contributions to […]
Health data analysis platforms for all: empowering novice and advanced users for maximum insights
Introduction to health data analysis Healthcare is one of the most data-rich industries and the creation of large datasets is becoming increasingly […]